As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Aims and Scope
Pediatric Rheumatology is an open access, peer-reviewed, online journal encompassing all aspects of clinical and basic research related to pediatric rheumatology and allied subjects.
The journal’s scope of diseases and syndromes include musculoskeletal pain syndromes, rheumatic fever and post-streptococcal syndromes, juvenile idiopathic arthritis, systemic lupus erythematosus, juvenile dermatomyositis, local and systemic scleroderma, Kawasaki disease, Henoch-Schonlein purpura and other vasculitides, sarcoidosis, inherited musculoskeletal syndromes, autoinflammatory syndromes, and others.
Funding support service
BMC provides a free open access funding support service to help authors discover and apply for APC funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs.
We also offer waivers and discounts to papers whose corresponding authors are from low-income and lower-middle-income economies, respectively. View the full list of countries here. For information about our discretionary waiver and discount policies for authors in financial need, please see here.
All discounts and waivers should be requested at the point of submission in Editorial Manager.
A free and open e-resource (endorsed by PReS) to aid the paediatric rheumatology community in their teaching, including interactive cases, pGALS videos and the pGALS app.
Alberto Martini, Editor-in-Chief
Alberto Martini is Professor of Pediatrics at the University of Genoa and has been Director of Pediatria II Reumatologia (EULAR Centre of Excellence in Rheumatology 2008-18) and of the Department of Pediatrics of the G Gaslini Institute, Genoa, Italy. Since March 2016 he is the Scientific Director of the G Gaslini Institute in Genoa. Prof Martini is Chairman of the Pediatric Rheumatology International Trial Organization (PRINTO) and has been President of the Paediatric Rheumatology European Society (2011-16) and Chairman of the EULAR Standing Committee on Pediatric Rheumatology (2013-16). He is also the author of more than 400 papers in peer reviewed journals related to pediatric rheumatic diseases.
Charles H Spencer, Editor-in-Chief
Charles H Spencer MD is the founding editor of the journal. He is a Professor of Pediatrics at the University of Mississippi in Jackson, MS and Division Head of Rheumatology at Batson Children's Hospital. He has provided leadership and helped develop pediatric rheumatology at Children's Hospital of New Orleans (LSU), University of Chicago and La Rabida Children's Hospitals, and Nationwide Children's Hospital and Ohio State in Columbus, Ohio USA. Over the last 20 years he has been selected yearly as a "Best Doctor in America" that recognizes the preferred top 5% of physicians chosen by other doctors. His career accomplishments have been recognized by being chosen for the Masters Award of the American College of Rheumatology in 2011 and for the James T Cassidy Award in Pediatric Rheumatology in 2013 of the American Academy of Pediatrics. He has been an advocate of bench to bedside research collaboration, medical student and resident education on pediatric rheumatology, and development of pediatric rheumatology everywhere in the world.
Official journal of
Annual Journal Metrics
64 days to first decision for reviewed manuscripts only
59 days to first decision for all manuscripts
102 days from submission to acceptance
21 days from acceptance to publication
2.595 - 2-year Impact Factor
2.931 - 5-year Impact Factor
1.373 - Source Normalized Impact per Paper (SNIP)
1.109 - SCImago Journal Rank (SJR)
279 Altmetric mentions